65,437 trials
Pulmonary Disease, Chronic Obstructive
Primary: Number of Participants Who Received COPD Prescription for Maintenance Treatment at Baseline — 735; 68; 554; 105 Participants
Pediatric Obesity · Mobile Technology · Addiction
Primary: %BMIp95 — -1.9; -1.2; -1.5 percent
HIV Infections · Hepatitis C · Risky Health Behavior
Primary: Syringe Sharing — 16; 167; 15; 175 Participants — p=<.01
Ocular Discomfort
Primary: Changes From Baseline (Day 1 Pre-dose) in Ocular Tolerability Using a Visual Analogue Scale (VAS) — -22.8; -30.1; -20.9; -20.9 mm — p=0.3474
Knee Osteoarthritis
Primary: Implant Survival for Aseptic Loosening — 95.0; 97.8 percentage of survival implants
Rotator Cuff Tear Arthropathy
Primary: Opiate Consumption in Patients Prescribed Ibuprofen Versus Placebo — 168.3; 210.9 morphine milligram equivalents
Chronic Pain · Intractable Pain · Low Back Pain
Primary: Perception Threshold — 157 percent change in perception threshold
Low Back Pain · Facet Joint Pain
Primary: Safety of Cryoneurolysis as Compared to Radiofrequency Ablation (RFA) — 0; 0 Participants
Chronic Kidney Disease Requiring Chronic Dialysis
Primary: C Reactive Protein - Marker of Systemic Inflammation — 7.3 mg/L
COVID-19
Primary: Sambucol Reduces the Severity of Symptoms by at Least 30% by Day 10 in People Who Are Symptomatic With the SARS-CoV-2 (COVID-19) Virus, Compared to Placebo. — 84.3; 86.5…
Genetic Predisposition
Primary: Change in Knowledge Score — 0.05; -0.08 score on a scale
Cardiac Arrest
Primary: Number of Participants With Death or Poor Neurologic Outcome at 6 Months — 89; 83 Participants
Cardiovascular Diseases
Primary: Percent Change in Circulating Concentration of Tumor Necrosis Factor Alpha (TNFα) — -1.03; 2 percent change
Tooth Loss · Ceramic Implant
Primary: Number of Implants That Survived — 157; 5 implants
Atrial Fibrillation
Primary: Number of Participants With Adverse Events — 0; 0 Participants